Cevimeline clinical trials
Also written Evoxac.
How each study uses cevimeline is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 11 Jan 2000 · EVOXAC · NDA 020989 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
5 studies that test it; most in 2009 (3)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2007 | 1 |
| 2009 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 2
Roxane Laboratories (2) · University of Kentucky (1) · American Academy of Otolaryngology-Head and Neck Surgery Foundation (1) · Daiichi Sankyo (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses cevimeline is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Efficacy of Cevimeline Versus Pilocarpine in the Secretion of SalivaCompletedNot applicableUniversity of KentuckyNCT01690052Written as Cevimeline
- Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fasted ConditionsCompletedEarly Phase 1Roxane LaboratoriesNCT01903122Written as Cevimeline
- Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fed ConditionsCompletedEarly Phase 1Roxane LaboratoriesNCT01903109Written as Cevimeline
- Study of the Effectiveness of Cevimeline on Oral Health in Patients With Radiation Induced XerostomiaCompletedPhase 4American Academy of Otolaryngology-Head and Neck Surgery FoundationNCT00466388Written as Cevimeline
- Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck CancerCompletedPhase 3Daiichi SankyoNCT00017511Written as cevimeline hydrochloride
Codes
What other systems call cevimeline · ClinicalTrials.gg INT003427
- MeSH (NLM) C059240cevimelineConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) K9V0CDQ56ECEVIMELINEConfirmed FDA, NLM
- RxNorm 44281One source FDA
- NCI Thesaurus C66873CevimelineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C059240 | cevimeline | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | K9V0CDQ56E | CEVIMELINE | Confirmed FDA, NLM |
| RxNorm | 44281 | — | One source FDA |
| NCI Thesaurus | C66873 | Cevimeline | One source FDA |
Also registered as cevimeline hydrochloride (UNII P81Q6V85NP · RxNorm 260036).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.